Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study

被引：0
|
作者：
Balko, Justin M.
Yao, Lydia
Zhang, Siwei
Fahey, Catherine
Haugh, Alexandra
Davis, Andrea
Mukherjee, Eric
Hammer, Christian
Phillips, Elizabeth J.
Bejan, Cosmin A.
Xu, Yaomin
Johnson, Douglas Buckner
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] UCSF Hem, Onc Fellowship, San Francisco, CA USA
[3] Univ Colorado, Denver, CO USA
[4] Genentech Inc, South San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10582
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
    Muntyanu, Anastasiya
    Netchiporouk, Elena
    Gerstein, William
    Gniadecki, Robert
    Litvinov, Ivan V.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (01) : 59 - 76
  • [42] Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Middha, Pooja
    Thummalapalli, Rohit
    Quandt, Zoe
    Balaratnam, Karmugi
    Cardenas, Eduardo
    Falcon, Christina J.
    Margaret Lung Group, Princess
    Gubens, Matthew A.
    Huntsman, Scott
    Khan, Khaleeq
    Li, Min
    Lovly, Christine M.
    Patel, Devalben
    Zhan, Luna Jia
    Liu, Geoffrey
    Aldrich, Melinda C.
    Schoenfeld, Adam
    Ziv, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [43] Distribution of immune-related adverse events (irAEs) across genitourinary (GU) malignancies.
    Mar, Nataliya
    Slaught, Matthew
    Kaakour, Dalia
    Azizi, Armon
    Valerin, Jennifer Brooke
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [44] Immune-Related Adverse Events (irAEs) in Cancer, with Inputs from a Nursing Expert: A Review
    Buch, Sajad Ahmad
    Baba, Mudasir Rashid
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (02) : 144 - 152
  • [45] Proactively Improving the Management of Immune-Related Adverse Events (irAEs) in a Community Cancer Program
    Dobrea, L.
    Nguyen, E. Esposito
    Maurice, J.
    Carandang, M.
    Boyd, D.
    Haimowitz, S.
    Gracie-King, L.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1065 - S1065
  • [46] Immune-related adverse events (IrAEs) as a predictor of response to immunotherapy in patients with lung cancer
    Sanchez Becerra, M. V.
    Martinez-Cabanes, R.
    Gonzalez-Lopez, A.
    Zhan-Zhou, E.
    Sotelo, V.
    Esteban, M.
    Robles, T.
    Camara, J. C.
    Cardena, A.
    Hernando, S.
    Hurtado, A.
    Moreno, D.
    Olier, C.
    Mielgo Rubio, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S808 - S809
  • [47] Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
    Zhou, Yixin
    Yu, Hui
    Chen, Chen
    Li, Anlin
    Zhang, Xuanye
    Qiu, Huijuan
    Du, Wei
    Fu, Sha
    Zhang, Li
    Hong, Shaodong
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [48] Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.
    Iacono, Donatella
    Vitale, Maria Grazia
    Cortiula, Francesco
    Macerelli, Marianna
    Cinausero, Marika
    Minisini, Alessandro Marco
    Valent, Francesca
    Tullio, Annarita
    Palmero, Lorenza
    Targato, Giada
    Zara, Diego
    Fasola, Gianpiero
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Incidence, risk factors, and outcomes of immune-related adverse events (irAEs) in a prospective, pan-tumor population
    Balaji, Aanika
    Alden, Stephanie Leigh
    Li, Howard
    Munjal, Kabeer
    Lipson, Evan J.
    Naidoo, Jarushka
    Cappelli, Laura
    Ged, Yasser
    Hoffman-Censits, Jean H.
    Mohindra, Rajat
    Garonce-Hediger, Rachel
    Seiwert, Tanguy Y.
    Bansal, Sanjay
    Tang, Laura
    Chandler, G. Scott
    Yarchoan, Mark
    Kao, Chester
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Impact of patient education on immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI)
    Berger, V. A.
    Jube, C.
    Forestier, A.
    Mitonneau, C.
    Humeau, H.
    Limouzin, S.
    Tiercin, M.
    Morliere, L.
    Geoffrois, L.
    Cabart, M.
    Bertholet, M.
    Llambrich-Molines, C.
    Breysse, S.
    Laghouati, S.
    Beaumont, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1285 - S1285
12345